Billy Wai-Lung Ng

Prof. Dr. Billy Wai-Lung Ng


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Molecular Cell
Verified
Journal Article
Closed access
FRFran Robson
Fran Robson
KKKhadija Shahed Khan
Khadija Shahed Khan
TLThi Khanh Le
Thi Khanh Le
CPClément Paris
Clément Paris
SDSinem Demirbag
Sinem Demirbag
BNBilly Wai-Lung Ng
Billy Wai-Lung Ng

4 November 2016 in Science
Verified
Journal Article
Closed access
PDF file
TWTom H. Wright
Tom H. Wright
BBBen J. Bower
Ben J. Bower
JCJustin M. Chalker
Justin M. Chalker
GBGonçalo J. L. Bernardes
Gonçalo J. L. Bernardes
RWRafal Wiewiora
Rafal Wiewiora
BDBenjamin G. Davis
Benjamin G. Davis
Radicals push proteins beyond genes: Chemically modifying proteins after their translation can expand their structural and functional roles (see the Perspective by Hofmann and Bode). Two related methods describe how to exploit free radical chemistry to form carbon-carbon bonds between amino acid residues and a selected functional group. Wright et al. added a wide range of functional groups to proteins containing dehydroalanine precursors, with borohydride mediating the radical chemistry. Yang et al. employed a similar approach, using zinc in combination with copper ions. Together, these results will be useful for introducing functionalities and labels to a wide range of proteins. Science , this issue pp. 597 and 623 ; see also p. 553

1 February 2020 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
FLFei Li
Fei Li
QHQingyuan Huang
Qingyuan Huang
TLTroy A. Luster
Troy A. Luster
HHHai Hu
Hai Hu
HZHua Zhang
Hua Zhang
KWKwok-Kin Wong
Kwok-Kin Wong
Despite substantial progress in lung cancer immunotherapy, the overall response rate in patients with KRAS-mutant lung adenocarcinoma (LUAD) remains low. Combining standard immunotherapy with adjuvant approaches that enhance adaptive immune responses—such as epigenetic modulation of antitumor immunity—is therefore an attractive strategy. To identify epigenetic regulators of tumor immunity, we constructed an epigenetic-focused single guide RNA library and performed an in vivo CRISPR screen in a KrasG12D/Trp53−/− LUAD model. Our data showed that loss of the histone chaperone Asf1a in tumor cells sensitizes tumors to anti–PD-1 treatment. Mechanistic studies revealed that tumor cell–intrinsic Asf1a deficiency induced immunogenic macrophage differentiation in the tumor microenvironment by upregulating GM-CSF expression and potentiated T-cell activation in combination with anti–PD-1. Our results provide a rationale for a novel combination therapy consisting of ASF1A inhibition and anti–PD-1 immunotherapy. Significance: Using an in vivo epigenetic CRISPR screen, we identified Asf1a as a critical regulator of LUAD sensitivity to anti–PD-1 therapy. Asf1a deficiency synergized with anti–PD-1 immunotherapy by promoting M1-like macrophage polarization and T-cell activation. Thus, we provide a new immunotherapeutic strategy for this subtype of patients with LUAD. See related commentary by Menzel and Black, p. 179. This article is highlighted in the In This Issue feature, p. 161

22 January 2018 in Journal of the American Chemical Society
Verified
Journal Article
Open access
MIMateusz Imiołek
Mateusz Imiołek
GKGogulan Karunanithy
Gogulan Karunanithy
BNBilly Wai-Lung Ng
Billy Wai-Lung Ng
ABAndrew J. Baldwin
Andrew J. Baldwin
VGVeronique Emilie Gouverneur
Veronique Emilie Gouverneur
BDBenjamin G. Davis
Benjamin G. Davis
The incorporation of fluorine can not only significantly facilitate the study of proteins but also potentially modulate their function. Whilst some biosynthetic methods allow global residue-replacement methods, post-translational fluorination would constitute a fast and efficient alternative. Here, we reveal a mild method for direct protein radical trifluoromethylation at native residues as a strategy for symmetric-multi-fluorine incorporation on mg scales with high recoveries. High selectivity towards tryptophan residues enhanced the utility of this direct trifluoromethylation technique allowing ready study of fluorinated protein constructs using 19F-NMR.

4 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LZLei Zhao
Lei Zhao
ZLZhongqi Li
Zhongqi Li
JVJoaquim S. L. Vong
Joaquim S. L. Vong
XCXinyi Chen
Xinyi Chen
HLHei-Ming Lai
Hei-Ming Lai
HKHo Ko
Ho Ko
The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovascular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation-dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which prominently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed transcriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.

25 July 2022 in Trends in Microbiology
Verified
Journal Article
Closed access
HLHaohua Li
Haohua Li
CEChristina Ernst
Christina Ernst
MKMarta Kolonko-Adamska
Marta Kolonko-Adamska
BGBeata Greb-Markiewicz
Beata Greb-Markiewicz
JMJackie Man
Jackie Man
BNBilly Wai-Lung Ng
Billy Wai-Lung Ng